(Q72355315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

26 October 2019

main subject

1 reference

C Quereda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

G G Otero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

A Pardo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

L Orte

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

M Rivera

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

A Gonzalo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

J Pascual

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

J Ortuño

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 April 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

555-561

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

Anticardiolipin antibodies, livedo reticularis, and major cerebrovascular and renal disease in systemic lupus erythematosus

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Anticardiolipin antibodies in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Thrombosis in patients with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Significance of anti-phospholipid antibodies in patients with lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Recurrent thrombosis and renal vascular disease in patients with a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Renal thrombotic microvascular disease associated with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Lupus-like in vitro anticoagulant activity in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Highlights of the second international conference on systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Anticardiolipin response in acute infections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Detection of lupus anticoagulant in patients attending an anticoagulation clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

The lupus anticoagulant and its role in thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Anticardiolipin antibodies in patients with infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Thrombotic Microangiopathic Nephropathy in Scleroderma and Lupus Anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Failure to demonstrate the lupus anticoagulant in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980378-7

7 January 2021

10.1016/S0272-6386(12)80378-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8154492%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference